Outcomes after supratherapeutic escitalopram ingestions.
about
Escitalopram for the management of major depressive disorder: a review of its efficacy, safety, and patient acceptability.Escitalopram for the treatment of major depression and anxiety disorders.Escitalopram causes fewer seizures in human overdose than citalopram.Corrected QT interval prolongation after an overdose of escitalopram, morphine, oxycodone, zopiclone and benzodiazepines.Bilateral ankle oedema in a patient taking escitalopram.
P2860
Outcomes after supratherapeutic escitalopram ingestions.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Outcomes after supratherapeutic escitalopram ingestions.
@ast
Outcomes after supratherapeutic escitalopram ingestions.
@en
type
label
Outcomes after supratherapeutic escitalopram ingestions.
@ast
Outcomes after supratherapeutic escitalopram ingestions.
@en
prefLabel
Outcomes after supratherapeutic escitalopram ingestions.
@ast
Outcomes after supratherapeutic escitalopram ingestions.
@en
P2093
P1476
Outcomes after supratherapeutic escitalopram ingestions.
@en
P2093
David Watts
Frank LoVecchio
Jason Knight
Joseph Winchell
Tim McDowell
P356
10.1016/J.JEMERMED.2005.04.013
P577
2006-01-01T00:00:00Z